Insider Transactions in Q1 2021 at Vericel Corp (VCEL)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,178
-29.45%
|
$64,790
$55.55 P/Share
|
|
Mar 31
2021
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
-
|
|
Mar 30
2021
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
17,924
-15.36%
|
$914,124
$51.13 P/Share
|
|
Mar 30
2021
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,438
+21.7%
|
$334,380
$10.95 P/Share
|
|
Mar 30
2021
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.11%
|
$187,500
$25.8 P/Share
|
|
Mar 29
2021
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
40,000
-5.17%
|
$2,040,000
$51.08 P/Share
|
|
Mar 19
2021
|
Alan L Rubino |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+39.54%
|
$225,000
$45.2 P/Share
|
|
Mar 01
2021
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
40,000
-4.26%
|
$1,920,000
$48.33 P/Share
|
|
Mar 01
2021
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,355
+3.84%
|
$113,420
$4.2 P/Share
|
|
Feb 11
2021
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,516
-21.8%
|
$74,284
$49.23 P/Share
|
|
Feb 11
2021
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+33.48%
|
-
|
|
Feb 11
2021
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,267
-1.47%
|
$160,083
$49.23 P/Share
|
|
Feb 11
2021
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+3.26%
|
-
|
|
Feb 11
2021
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
738
-2.91%
|
$36,162
$49.23 P/Share
|
|
Feb 11
2021
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,625
+6.02%
|
-
|
|
Feb 06
2021
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,078
-1.41%
|
$144,666
$47.18 P/Share
|
|
Feb 06
2021
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,938
+3.08%
|
-
|
|
Feb 06
2021
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
264
-1.1%
|
$12,408
$47.18 P/Share
|
|
Feb 06
2021
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
650
+2.64%
|
-
|
|
Feb 06
2021
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
892
-20.53%
|
$41,924
$47.18 P/Share
|
|
Feb 06
2021
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+30.14%
|
-
|